International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies

Archives

TuEngr+Logo
:: International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies

http://TuEngr.com



ISSN 2228-9860
eISSN 1906-9642
CODEN: ITJEA8


FEATURE PEER-REVIEWED ARTICLE

Vol.13(11)(2022)

  • Changes in Lipid Metabolism in Patients with Ischemic Heart Disease Associated with Intestinal Dysbiosis

    Diana Arsenovna Mirzoeva, Kistaman Muradovna Magomedmirzoeva (Rostov State Medical University, Rostov-on-Don, RUSSIA),
    Asiyat Abdullayevna Albaskhanova (Astrakhan State Medical University, Astrakhan, RUSSIA),
    Dzhovkhar Vakhaevich Gunashev (Chechen State University named after A.A. Kadyrov, Grozny, Republic of Chechnya, RUSSIA),
    Khetag Zaurbekovich Gazanov, Mahmud Bekhanovich Sadilov (North Ossetian State Medical Academy, Vladikavkaz, Republic of North Ossetia-Alania, RUSSIA),
    Aleksandr Alekseevich Osadchii (Moscow State University, Moscow, RUSSIA),
    Igor Spartakovich Baklanov (North Caucasus Federal University, Stavropol, RUSSIA),
    Madina Borkhaevna Bolgucheva (Ingush State University, Magas, Republic of Ingushetia, RUSSIA),
    Malika Razhabovna Zhaboeva (Kabardino-Balkarian State University named after H.M. Berbekov, Nalchik, Republic of Kabardino-Balkaria, RUSSIA).

    Discipline: Medicine (Cardiology).

    ➤ FullText

    doi: 10.14456/ITJEMAST.2022.216

    Keywords:Cardiovascular diseases, Coronary heart disease, Chylomicron, Dysbiosis

    Abstract
    Mortality from cardiovascular diseases (CVD) currently occupies one of the leading positions. The main diseases that cause death are coronary heart disease (CHD). In the course of a retrospective study, the medical histories of 167 patients with chronic CHD were analyzed. The experiment included women aged 47-55 years with a history of information about the presence of disorders from lipid metabolism and intestinal dysbiosis of varying degrees. Thus, in patients with coronary heart disease against the background of intestinal dysbiosis of III-IV degrees, significant lipid metabolism disorders associated with an increase in cholesterol, LDL and TG are observed. Based on the data obtained on the absence of significant changes in liver tests, it can be concluded that the leading role of the exogenous lipid intake pathway in the formation of dyslipidemia.

    Paper ID: 13A11F

    Cite this article:

    Mirzoeva, D.A., Magomedmirzoeva, K.M., Albaskhanova, A.A., Gunashev, Dzh. V., Gazanov, Kh. Z., Sadilov, M.B., Osadchii, A.A., Baklanov, I.S., Bolgucheva, M.B., Zhaboeva, M. (2022). Changes in Lipid Metabolism in Patients with Ischemic Heart Disease Associated with Intestinal Dysbiosis. International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies, 13(11), 13A11F, 1-7. http://TUENGR.COM/V13/13A11F.pdf DOI: 10.14456/ITJEMAST.2022.216

References

  1. Yakovenko EP, Agafonova NA, Ivanov AN, Yakovenko AV, Aldiyarova MA, Volosheinikova TV, Grigoryeva YV, Soluyanova IP. Tsitoprotektor rebamipid v terapii vospalitel'nykh i erozivno-yazvennykh porazhenii zheludochno-kishechnogo trakta (The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract). Ter Arkh. 2016;88(4):88-92. Russian. DOI: 10.17116/terarkh301688488-92
  2. Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124-37.
  3. Defrees DN, Bailey J. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Prim Care. 2017;44(4):655-671. DOI: 10.1016/j.pop.2017.07.009
  4. Areshidze DA, Mischenko DV, Makartseva LA, Rzhepakovsky IV, Nagdalian AA. Some functional measures of the organism of rats at modeling of ischemic heart disease in two different ways. Entomology and Applied Science, 2018;5(4):2349-2864
  5. Fritsch J, Garces L, Quintero MA, Pignac-Kobinger J, Santander AM, Fernández I, Ban YJ, Kwon D, Phillips MC, Knight K, Mao Q. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clinical gastroenterology and hepatology. 2021;19(6):1189-99. DOI: 10.1016/j.cgh.2020.05.026
  6. Cristofori F, Indrio F, Miniello VL, De Angelis M, Francavilla R. Probiotics in Celiac Disease. Nutrients. 2018;10(12):1824. DOI: 10.3390/nu10121824. PMID: 30477107; PMCID: PMC6316269.
  7. Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med. 2019;23(4):2343-2350. DOI: 10.1111/jcmm.14195
  8. Bazhenova AA, Guryanova NI, Guryanov GS, Alieva HAV, Kachmazova DT, Khripunova A A, et al. In-Vitro Study of the Properties of Components for the Synthesis of Sorbent for Low-Density Lipoprotein Apheresis. Pharmacophore. 2021;12(3):37-41. DOI: 10.51847/BsjhKFW0Kd
  9. Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X, Yang R, Jiang R, Xu Y, Qin H. Dysbiosis signatures of gut microbiota in coronary artery disease. Physiol Genomics. 2018 Oct 1;50(10):893-903. DOI: 10.1152/physiolgenomics.00070.2018
  10. Alberts AW. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis. Cardiology. 1990;77 Suppl 4:14-21. DOI: 10.1159/000174688
  11. Xie, Zq., Liang, G., Zhang, L. et al. Molecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes: a comparative study with lovastatin. Acta Pharmacol Sin 2009; 30, 1262–1275. DOI: 10.1038/aps.2009.126
  12. Jiang, SY., Li, H., Tang, JJ. et al. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat Commun 2018; 9, 5138. DOI: 10.1038/s41467-018-07590-3
  13. Ranjha MMAN, Shafique B, Rehman A, Mehmood A, Ali A, Zahra SM, Roobab U, Singh A, Ibrahim SA and Siddiqui SA (2022). Biocompatible Nanomaterials in Food Science, Technology, and Nutrient Drug Delivery: Recent Developments and Applications. Front. Nutr. 8:778155. DOI: 10.3389/fnut.2021.778155
  14. Soliman GA. Dietary Cholesterol and the Lack of Evidence in Cardiovascular Disease. Nutrients. 2018; 10(6):780. DOI: 10.3390/nu10060780
  15. Maslova AY, Bazaeva KL, Abdullaeva ZA, Khazamova SO, Zeusheva KA, Grechkina TA, Semkina EN, Abramov MA, Mishvelov AE, Povetkin SN. Astrocytes and their Phenomenal Possibilities in the Treatment of Various Neurodegenerative Disorders: An Overview. Journal of Pharmaceutical Research International. 2021;33(33A): 60-68. DOI: 10.9734/jpri/2021/v33i33A31772
  16. Shahida Anusha Siddiqui, Nur Alim Bahmid, Ahmed Taha, Ibrahim Khalifa, Sipper Khan, Hadis Rostamabadi & Seid Mahdi Jafari (2022) Recent advances in food applications of phenolic-loaded micro/nanodelivery systems, Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2022.2056870
  17. Gil-Zamorano, J., Tomé-Carneiro, J., Lopez de las Hazas, MC. et al. Intestinal miRNAs regulated in response to dietary lipids. Sci Rep 2020; 10, 18921. DOI: 10.1038/s41598-020-75751-w
  18. Tian R, Liu H, Feng S, Wang H, Wang Y, Wang Y, Liang L, Xu H, Xing H, Zhang S. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis. Nutr Metab Cardiovasc Dis. 2021;31(5):1454-1466. DOI: 10.1016/j.numecd.2021.01.007
  19. Wilkins, L.J., Monga, M. & Miller, A.W. Defining Dysbiosis for a Cluster of Chronic Diseases. Sci Rep 2019; 9,12918. DOI: 10.1038/s41598-019-49452-y
  20. Rzhepakovsky I, Anusha Siddiqui S, Avanesyan S, Benlidayi M, Dhingra K, Dolgalev A, Enukashvily N, Fritsch T, Heinz V, Kochergin S, Nagdalian A, Sizonenko M, Timchenko L, Vukovic M, Piskov S, Grimm WD. Anti-arthritic effect of chicken embryo tissue hydrolyzate against adjuvant arthritis in rats (X-ray microtomographic and histopathological analysis). Food Sci Nutr. 2021;9(10):5648-5669. DOI: 10.1002/fsn3.2529
  21. Akram, Muhammad & Riaz, Muhammad & Noreen, Sarwat & Shariati, Mohammad Ali & Shaheen, Ghazala & Akhter, Naheed & Parveen, Farnaz & Zafar, Sadia & Ghauri, Aymen & Riaz, Zerfishan & Khan, Fahad & Kausar, Shamaila & Zainab, Rida. Therapeutic potential of medicinal plants for the management of Scabies. Dermatologic Therapy. 2020, 33. DOI: 10.1111/dth.13186
  22. Blinov AV, Nagdalian AA, Povetkin SN, Gvozdenko AA, Verevkina MN, Rzhepakovsky IV, Lopteva MS, Maglakelidze DG, Kataeva TS, Blinova AA, Golik AB, Osipchuk GV, Shariati MA. Surface-Oxidized Polymer-Stabilized Silver Nanoparticles as a Covering Component of Suture Materials. Micromachines. 2022; 13(7):1105. DOI: 10.3390/mi13071105
  23. Yasnaya MA, Blinov AV, Blinova AA, Shevchenko IM. Determination of optimal modes for measuring the size of colloidal particles by photon-correlation spectroscopy and acoustic spectroscopy. Physical and Chemical Aspects of the Study of Clusters Nanostructures and Nanomaterials. 2020;12:232-242
  24. Siddiqui S. A., Ahmad A., Siddiqui A. A. and Chaturvedi P. Stability Analysis of a Cantilever Structure using ANSYS and MATLAB. 2nd International Conference on Intelligent Engineering and Management (ICIEM), 2021, 7-12, DOI: 10.1109/ICIEM51511.2021.9445357
  25. Liu Z, Li J, Liu H, Tang Y, Zhan Q, Lai W, Ao L, Meng X, Ren H, Xu D, Zeng Q. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease. Atherosclerosis. 2019;284:121-128. DOI: 10.1016/j.atherosclerosis.2018.11.038
  26. Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, Tanase DM. Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications. J Diabetes Res. 2018;2018:5205126. DOI: 10.1155/2018/5205126
  27. Khalil A, Batool A, Arif S. Healthy Cattle Microbiome and Dysbiosis in Diseased Phenotypes. Ruminants. 2022; 2(1):134-156. DOI: 10.3390/ruminants2010009


Other issues:
Vol.13(10)(2022)
Vol.13(9)(2022)
Vol.13(8)(2022)
Archives




Call-for-Papers

Call-for-Scientific Papers
Call-for-Research Papers:
ITJEMAST invites you to submit high quality papers for full peer-review and possible publication in areas pertaining engineering, science, management and technology, especially interdisciplinary/ cross-disciplinary/ multidisciplinary subjects.

To publish your work in the next available issue, your manuscripts together with copyright transfer document signed by all authors can be submitted via email to Editor @ TuEngr.com (please see all detail from Instructions for Authors)



Publication and peer-reviewed process:
After the peer-review process, articles will be on-line published in the available next issue. However, the International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies cannot guarantee the exact publication time as the process may take longer time, subject to peer-review approval and adjustment of the submitted articles.